Price:
Rs. 5,355.00
Sample Type: Positive MGIT Tube
Fasting Not Required
Notes: A0116
Frequently Asked Questions (FAQ's):
What is the AFB XDR Screen by Hain LPA?
It is a molecular test that detects genetic mutations associated with extensively drug-resistant TB (XDR-TB) using a Line Probe Assay.
Why is this test performed on extra-pulmonary samples?
Extra-pulmonary TB can occur outside the lungs, and this test helps detect drug resistance in such infections for accurate treatment.
Which drug resistances can this test identify?
It detects resistance-related mutations to fluoroquinolones and second-line injectable drugs, along with previously assessed first-line drug markers.
How is the sample collected?
The type of specimen depends on the site of infection (e.g., lymph node aspirate, tissue, body fluids) as advised by your clinician.
Do I need any preparation before the test?
No special preparation is required for providing extra-pulmonary samples.
How does Metropolis Healthcare perform this test?
Metropolis uses advanced Hain LPA technology to identify TB resistance patterns quickly and accurately.
How long do the results take?
Molecular results are typically available faster than culture-based methods, depending on the sample type.
Why is XDR-TB detection important?
Early identification of XDR-TB allows clinicians to design appropriate treatment regimens and prevent treatment failure